FDA Panel Rules Avastin Unsafe For Breast Cancer Use
Following a two-day hearing, a U.S. Food and Drug Administration advisory panel on Wednesday unanimously voted to yank approval for the use of Genentech Inc.'s drug Avastin in treating breast cancer...To view the full article, register now.
Already a subscriber? Click here to view full article